Susquehanna International Group’s Neuronetics STIM Stock Holding History

Susquehanna International Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$51.5K	Buy	35,500 +8,000	+29%	+$12.7K	﹤0.01%	12631
2025 Q4	$38K	Sell	27,500 -2,400	-8%	-$5.02K	﹤0.01%	11831
2025 Q3	$81.6K	Buy	29,900 +14,200	+90%	+$50.4K	﹤0.01%	11673
2025 Q2	$54.8K	Buy	+15,700	New	+$62K	﹤0.01%	12084
2023 Q1	–	Sell	-48,100	Closed	-$330K	–	13469
2022 Q4	$330K	Buy	+48,100	New	+$227K	﹤0.01%	8860
2021 Q3	–	Sell	-42,600	Closed	-$682K	–	13531
2021 Q2	$682K	Buy	42,600 +10,300	+32%	+$142K	﹤0.01%	8807
2021 Q1	$400K	Buy	32,300 +13,700	+74%	+$210K	﹤0.01%	9988
2020 Q4	$207K	Buy	+18,600	New	+$140K	﹤0.01%	9980

Other funds holding STIM

MAM

Madryn Asset Management New York $34.1M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's STIM Position: Q1 2026 in Review

Susquehanna International Group reduced its Neuronetics (STIM) stake by 73% in Q1 2026, selling an estimated $373K and leaving 86,481 shares worth $125K. The position accounts for ﹤0.01% of the portfolio, ranked #12184.

Susquehanna International Group first reported a position in STIM in Q1 2021 and has held it in 16 quarters since. The position peaked at $2.8M in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

Susquehanna International Group held 86,481 shares of Neuronetics worth $125K as of Q1 2026.
Susquehanna International Group sold 235,080 Neuronetics shares in Q1 2026, an estimated $373K.
Neuronetics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12184 holding.
Susquehanna International Group first reported a position in Neuronetics in Q1 2021 and has held it in 16 quarters since.
Susquehanna International Group's Neuronetics position peaked at $2.8M in Q1 2025.
99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.